Analysis of circulating tumor DNA identifies distinct therapeutic response to intraperitoneal and intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis

Hong Yuan(People's Hospital of Xinjiang Uygur Autonomous Region), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Shengzhou Wang(Genecast (China)), Fei Xu(Genecast (China)), Huan Zhang(East China University of Science and Technology), Min Shi(Hebei Medical University), Chao Yan(Shanghai Jiao Tong University), Di Liu(Chinese Academy of Sciences), Jun Zhang(Qingdao University)
Therapeutic Advances in Medical Oncology
January 1, 2024
10.1177/17588359231225038
Cited by 10

Related Papers

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae
|Cell Metabolism|2019|521
Virus genomes reveal factors that spread and sustained the Ebola epidemic
|Nature|2017|460
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400